Keywords: Almirall, Aclidinium, COPD, European Commission, Eklira, Bretaris Genuair, Menarini

Almirall's aclidinium approved in Europe for COPD maintenance treatment

Article | 25 July 2012

Print This

Spain’s leading drugmaker, Almirall (ALM: MC) says that the European Commission has granted marketing approval to Eklira/Bretaris ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in